# Heart Failure Therapy and Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

> **NCT06671314** · — · COMPLETED · sponsor: **Novartis** · enrollment: 42494 (actual)

## Conditions studied

- Heart Failure With Reduced Ejection Fraction
- Heart Failure With Preserved Ejection Fraction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06671314
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-02
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 42494 (ACTUAL)
- **Last updated:** 2024-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06671314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06671314, "Heart Failure Therapy and Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06671314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*